CCL6/C10 Antibody (RM0183-7J13) [PE/Cy5.5]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12420PECY55
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry
Label
PE/Cy5.5 (Excitation = 488 nm, Emission = 695 nm)
Antibody Source
Monoclonal Rat IgG2 Clone # RM0183-7J13
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse recombinant CCL6/C10
Clonality
Monoclonal
Host
Rat
Isotype
IgG2
Applications for CCL6/C10 Antibody (RM0183-7J13) [PE/Cy5.5]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined. For optimal results using our Tandem dyes, please avoid prolonged exposure to light or extreme temperature fluctuations. These can lead to irreversible degradation or decoupling. When staining intracellular targets, specific attention to the fixation and permeabilization steps in your flow protocol may be required. Please contact our technical support team at technical@novusbio.com if you have any questions.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: CCL6/C10
Alternate Names
C10, MRP-1, SCYA6
Gene Symbol
Ccl6
Additional CCL6/C10 Products
Product Documents for CCL6/C10 Antibody (RM0183-7J13) [PE/Cy5.5]
Product Specific Notices for CCL6/C10 Antibody (RM0183-7J13) [PE/Cy5.5]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...